# BPC-157 vs VIP: How They Differ | PepVault

Source: https://pepvault.app/peptides/compare/bpc-157-vs-vip

Last updated: 2026-09-30

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Library](https://pepvault.app/peptides) [Comparisons](https://pepvault.app/peptides/compare) BPC-157 vs VIP

Compared side by side

# BPC-157 vs VIP: how they differ

Reviewed September 2026 [How we check the library](https://pepvault.app/about#library) [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The short answer

BPC-157 is a peptide derived from a protective protein in human gastric juice that, in animal studies, speeds the repair of tendons, ligaments, muscle and gut lining. VIP is a neuropeptide the body uses to relax blood vessels and steer immune signaling, used mostly as a nasal spray in protocols for chronic inflammatory response syndrome (CIRS) and mold illness. VIP’s human evidence is small open-label case series, and BPC-157’s is three small uncontrolled pilots.

## Side by side

| Compared | [BPC-157](https://pepvault.app/peptides/bpc-157) | [VIP](https://pepvault.app/peptides/vip) |
| --- | --- | --- |
| Category | Healing & recovery | Healing & recovery |
| Also known as | Body Protection Compound 157, BPC157 | Vasoactive Intestinal Peptide, VIP neuropeptide |
| What it is | A peptide derived from a protective protein in your stomach. | A neuropeptide your body uses to relax blood vessels and steer immune signaling; in animal studies it's a powerful anti-inflammatory. |
| How it works | Synthetic pentadecapeptide derived from a protein in human gastric juice. In animal studies it promotes angiogenesis, speeds tendon, ligament and muscle healing, modulates dopamine and serotonin systems, and protects the gut lining. | Neuropeptide with potent anti-inflammatory effects in animal and cell studies; it also relaxes blood vessels and helps regulate the autonomic nervous system. Its effect on mast cells is mixed: in human mast cells in the lab it can trigger them. Used mainly in CIRS (chronic inflammatory response syndrome) and mold-illness protocols, a use that rests on open-label case series from one clinical group. |
| Commonly reported | Faster recovery from tendon and ligament injuries, and a calmer gut. It's one of the most widely used peptides in the community; the human studies so far are three small uncontrolled pilots. | Flushing or lightheadedness soon after a dose, especially early on, and for people on those protocols a slow lift in brain fog and fatigue over weeks to months. The human evidence is small open-label case series. |
| Studied range | Research range: 200–500 mcg. Studied in research — not a recommendation. | Research range: 50 mcg. Studied in research — not a recommendation. |
| How often | Once or twice daily | 2x daily, intranasal |
| Half-life | ~4–6 hours (community estimate for SubQ; not measured in people: in rats and dogs it cleared in under 30 minutes) | ~2 min IV; intranasal lasts longer locally |
| Route | SubQ injection, IM injection, Oral (less studied) | Intranasal (primary), SubQ injection |
| Typical run | Typically 4–12 weeks. Many run until injury resolves then stop. Some run indefinitely at lower doses. Opinions vary widely. | Used in defined cycles in CIRS protocols, often 4+ weeks. Practitioner guidance recommended. |
| Evidence | Emerging: primarily preclinical / limited human data | Moderate: animal studies + some human data |
| Common side effects | Nausea (rare), injection site irritation, vivid dreams, dizziness | Flushing, hypotension at higher doses, headache, lightheadedness |

Typical run: Community practice — opinions vary. Not a clinical recommendation.

<!--promo-->

PepVault for iPhone

## Taking BPC-157 or VIP? Log it in PepVault

Each dose, each vial and your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## Week by week

Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.

### BPC-157

- Day 1–7 Week one: early hints, for some
- Day 7–14 Pain often starts to ease
- Day 14–21 Pain often eases by week three
- Day 21–28 Many report a calmer gut
- Day 28–42 The slower part of repair
- Day 42–56 Six weeks in: taking stock
- Day 84+ Past week 12, the data runs thin

[Every card for BPC-157, with its sources](https://pepvault.app/peptides/bpc-157#weeks)

### VIP

- Day 1–14 The first two weeks
- Day 14–60 A slow arc, not a quick change
- Day 60–120 The long arc

[Every card for VIP, with its sources](https://pepvault.app/peptides/vip#weeks)

## Together or one or the other

BPC-157 and VIP are a common stack: VIP lists BPC-157 among its common stacks.

Community · VIP

### An inflammation-focused trio

Three angles at once: VIP to damp inflammation, LL-37 against microbes, and BPC-157 for gut and tissue repair. Used together in some mold-illness practitioner protocols; no study has tested the combination.

## With this comparison

### BPC-157

- [BPC-157: the full reference](https://pepvault.app/peptides/bpc-157)
- [BPC-157 dose guide](https://pepvault.app/lab/dosage/bpc-157)

### VIP

- [VIP: the full reference](https://pepvault.app/peptides/vip)
- [VIP dose guide](https://pepvault.app/lab/dosage/vip)

### Mixing charts

- [BPC-157 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/bpc-157-5mg)
- [BPC-157 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/bpc-157-10mg)

### Studies

- [BPC-157: 10 of 12 women reported full interstitial cystitis relief](https://pepvault.app/research/bpc-157-lee-2024)
- [BPC-157: 14 of 16 reported knee pain relief in a chart review](https://pepvault.app/research/bpc-157-lee-2021)
- [BPC-157 closed duodenocolic fistulas in rats](https://pepvault.app/research/bpc-157-vukusic-2024)
- [All 6 studies](https://pepvault.app/research#bpc-157)
- [VIP (aviptadil): discharge at 7.8 vs 10 days in COVID-19](https://pepvault.app/research/vip-esendagli-2025)
- [VIP fragment VIP10-28 boosted, not blocked, skin vessel widening](https://pepvault.app/research/vip-wilkins-2005)
- [VIP: peak flow rose 26 l/min in severe asthma, less than salbutamol](https://pepvault.app/research/vip-morice-1986)
- [All 4 studies](https://pepvault.app/research#vip)

### Compared with

- [Retatrutide vs BPC-157](https://pepvault.app/peptides/compare/retatrutide-vs-bpc-157)
- [Semaglutide vs BPC-157](https://pepvault.app/peptides/compare/semaglutide-vs-bpc-157)
- [BPC-157 vs TB-500](https://pepvault.app/peptides/compare/bpc-157-vs-tb-500)
- [KPV vs BPC-157](https://pepvault.app/peptides/compare/kpv-vs-bpc-157)
- [GHK-Cu vs BPC-157](https://pepvault.app/peptides/compare/ghk-cu-vs-bpc-157)
- [BPC-157 vs Thymosin Beta-4](https://pepvault.app/peptides/compare/bpc-157-vs-thymosin-beta-4)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Subcutaneous (SubQ)](https://pepvault.app/glossary/subcutaneous)
- [Intramuscular (IM)](https://pepvault.app/glossary/intramuscular)
- [Intranasal](https://pepvault.app/glossary/intranasal)
- [Half-life](https://pepvault.app/glossary/half-life)
- [Cycle](https://pepvault.app/glossary/cycle)
- [Stack](https://pepvault.app/glossary/stack)

## Questions people ask

### How long do BPC-157 and VIP last?

The half-life of BPC-157 is ~4–6 hours (community estimate for SubQ; not measured in people: in rats and dogs it cleared in under 30 minutes). The half-life of VIP is ~2 min IV; intranasal lasts longer locally.

### How often are BPC-157 and VIP taken?

BPC-157: once or twice daily. Routes: SubQ injection, IM injection, oral (less studied). VIP: 2x daily, intranasal. Routes: Intranasal (primary), subQ injection.

### How are BPC-157 and VIP dosed in research?

The research range for BPC-157 is 200–500 mcg. The research range for VIP is 50 mcg. Studied in research — not a recommendation.

### What are the common side effects of BPC-157 and VIP?

For BPC-157, the library lists: nausea (rare), injection site irritation, vivid dreams, dizziness. For VIP: flushing, hypotension at higher doses, headache, lightheadedness.

### Are BPC-157 and VIP taken together?

BPC-157 and VIP are a common stack: VIP lists BPC-157 among its common stacks. Three angles at once: VIP to damp inflammation, LL-37 against microbes, and BPC-157 for gut and tissue repair. Used together in some mold-illness practitioner protocols; no study has tested the combination.

## Each one in full

- [BPC-157: dosage, half-life & reference guide](https://pepvault.app/peptides/bpc-157)
- [VIP: dosage, half-life & reference guide](https://pepvault.app/peptides/vip)
- [BPC-157 dose guide](https://pepvault.app/lab/dosage/bpc-157)
- [VIP dose guide](https://pepvault.app/lab/dosage/vip)

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking BPC-157 or VIP? Log it in PepVault

Each dose, each vial and your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking BPC-157 or VIP? Log it in PepVault

Each dose, each vial and your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this comparison

### BPC-157

- [BPC-157: the full reference](https://pepvault.app/peptides/bpc-157)
- [BPC-157 dose guide](https://pepvault.app/lab/dosage/bpc-157)

### VIP

- [VIP: the full reference](https://pepvault.app/peptides/vip)
- [VIP dose guide](https://pepvault.app/lab/dosage/vip)

### Mixing charts

- [BPC-157 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/bpc-157-5mg)
- [BPC-157 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/bpc-157-10mg)

### Studies

- [BPC-157: 10 of 12 women reported full interstitial cystitis relief](https://pepvault.app/research/bpc-157-lee-2024)
- [BPC-157: 14 of 16 reported knee pain relief in a chart review](https://pepvault.app/research/bpc-157-lee-2021)
- [BPC-157 closed duodenocolic fistulas in rats](https://pepvault.app/research/bpc-157-vukusic-2024)
- [All 6 studies](https://pepvault.app/research#bpc-157)
- [VIP (aviptadil): discharge at 7.8 vs 10 days in COVID-19](https://pepvault.app/research/vip-esendagli-2025)
- [VIP fragment VIP10-28 boosted, not blocked, skin vessel widening](https://pepvault.app/research/vip-wilkins-2005)
- [VIP: peak flow rose 26 l/min in severe asthma, less than salbutamol](https://pepvault.app/research/vip-morice-1986)
- [All 4 studies](https://pepvault.app/research#vip)

### Compared with

- [Retatrutide vs BPC-157](https://pepvault.app/peptides/compare/retatrutide-vs-bpc-157)
- [Semaglutide vs BPC-157](https://pepvault.app/peptides/compare/semaglutide-vs-bpc-157)
- [BPC-157 vs TB-500](https://pepvault.app/peptides/compare/bpc-157-vs-tb-500)
- [KPV vs BPC-157](https://pepvault.app/peptides/compare/kpv-vs-bpc-157)
- [GHK-Cu vs BPC-157](https://pepvault.app/peptides/compare/ghk-cu-vs-bpc-157)
- [BPC-157 vs Thymosin Beta-4](https://pepvault.app/peptides/compare/bpc-157-vs-thymosin-beta-4)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Subcutaneous (SubQ)](https://pepvault.app/glossary/subcutaneous)
- [Intramuscular (IM)](https://pepvault.app/glossary/intramuscular)
- [Intranasal](https://pepvault.app/glossary/intranasal)
- [Half-life](https://pepvault.app/glossary/half-life)
- [Cycle](https://pepvault.app/glossary/cycle)
- [Stack](https://pepvault.app/glossary/stack)

<!--promo-->

PepVault for iPhone

## Taking BPC-157 or VIP? Log it in PepVault

Each dose, each vial and your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## More comparisons

- [All peptide comparisons](https://pepvault.app/peptides/compare)
- [Retatrutide vs BPC-157](https://pepvault.app/peptides/compare/retatrutide-vs-bpc-157)
- [Semaglutide vs BPC-157](https://pepvault.app/peptides/compare/semaglutide-vs-bpc-157)
- [BPC-157 vs TB-500](https://pepvault.app/peptides/compare/bpc-157-vs-tb-500)
- [KPV vs BPC-157](https://pepvault.app/peptides/compare/kpv-vs-bpc-157)
- [GHK-Cu vs BPC-157](https://pepvault.app/peptides/compare/ghk-cu-vs-bpc-157)
- [BPC-157 vs Thymosin Beta-4](https://pepvault.app/peptides/compare/bpc-157-vs-thymosin-beta-4)

## The library

- [The peptide reference library](https://pepvault.app/peptides)
- [Healing & recovery peptides](https://pepvault.app/peptides#healing)

## Free tools

- [The Dose Guide](https://pepvault.app/lab/dosage)
- [Half-life & active level](https://pepvault.app/tools/peptide-half-life-calculator)
- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
